Percutaneous absorption of bendroflumethiazide from gel and membrane-controlled gel systems: An in vitro and in vivo study

International Journal of Pharmaceutics

Volumn 152, Issue 2, 1997, Pages 165-178

  Viegas, Tacey X ^a   Hikal, Ahmed H ^b   Jones, Alan B ^b  

^a BIOCRYST PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Bendroflumethiazide; Gel; Hairless mouse skin; Membrane controlled; Percutaneous absorption; Rabbit

Indexed keywords

1 METHYL 2 PYRROLIDINONE; 2 PYRROLIDINONE; ALCOHOL; BENDROFLUMETHIAZIDE; CELLULOSE; ETHYLENE VINYL ACETATE COPOLYMER; MACROGOL 400; POLYACRYLIC ACID; POLYPROPYLENE; POLYURETHAN; SILICONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG STABILITY; GEL; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RABBIT; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0030858822     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00088-4     Document Type: Article

References (56)

1. Aboutaleb, A.E., Ali, A.A., Salama, R.B., 1977. Solubilization of some diuretics. Ind. J. Pharm. 39, 145-147.
2. Akhter, S.A., Barry, B.W., 1985. Absorption through human skin of ibuprofen and flurbiprofen: effect of dose variation, deposited drug films, occlusion and the penetration enhancer N-methyl 2-pyrrolidone. J. Pharm. Pharmacol. 37, 27-37.
3. Astley, J.P., Levine, M., 1976. Effect of dimethyl sulfoxide on permeability of human skin in vitro. J. Pharm. Sci. 65, 210-215.
4. Barry, B.W., 1987. Mode of action of penetration enhancers in human skin. J. Cont. Rel. 6, 85.
5. Barry, B.W., Bennett, S.L., 1987. Effect of penetration enhancers on the skin permeation of mannitol, hydrocortisone and progesterone through human skin. J. Pharm. Pharmacol. 39, 535-546.
6. Bronaugh, R.L., Congdon, E.R., Scheuplein, R.J., 1981. The effect of cosmetic vehicles on the permeation of N-nitrosodiethanolamine through excised human skin. J. Invest. Dermatol. 76, 94-96.
7. Chandrasekaran, S.K., Campbell, P.S., Michaels, A.S., 1977. Effect of dimethyl sulfoxide on the permeability of human skin. Am. Inst. Chem. Eng. J. 23, 810-816.
8. Chien, Y.W., 1987. Transdermal therapeutic systems. In: Robinson, J.R., Lee, V.H. (Eds.), Controlled Drug Delivery: Fundamentals and Applications, vol. 29. Marcel Dekker, New York, pp. 524-552.
9. Cleary, G.W., 1984. Transdermal controlled release systems. In: Langer, R.S., Wise, D.L. (Eds.), Medical Applications of Controlled Release, Classes of Systems, vol. 1. CRC Press, Boca Raton, FL, pp. 203-251.
10. Cooper, E.R., Merritt, E.W., Smith, R.L., 1985. Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J. Pharm. Sci. 74, 688.
11. Dalvi, U.G., Zatz, J.L., 1984. Effect of non-ionic surfactants on penetration of dissolved benzocaine through hairless mouse skin. J. Soc. Cosmet. Chem. 32, 87-94.
12. Di Colo, G., Carelli, V., Giannaccini, B., Serafini, M., Bottari, F., 1980. Vehicle effects in percutaneous absorption: in vitro study of influence of solvent power and microscopic viscosity of vehicle on benzocaine release from suspension hydrogels. J. Pharm. Sci. 69, 387-391.
13. Diez-Sales, O., Watkinson, A.C., Herraez-Dominguez, M., Javaloyes, C., Hadgraft, J., 1996. A mechanistic investigation of the in vitro human skin permeation effect of Azone®. Int. J. Pharm. 129, 33-40.
14. Durrheim, H., Flynn, G.L., Higuchi, W.I., Behl, C.R., 1980. Permeation of hairless mouse skin I: Experimental methods and comparison with human epidermal permeation by alkanols. J. Pharm. Sci. 69, 781-786.
15. Fares, H.M., Zatz, J.L., 1995. Measurement of drug release from topical gels using two types of apparatus. Pharm. Technol. 19, 52-58.
16. Florey, K., Russo-Alesi, F.M., 1976. Bendroflumethiazide. In: Florey, K. (Ed.), Analytical Profiles of Drug Substances, vol. 5. Academic Press, New York, pp. 2-19.
17. Flynn, G.L., Smith, R.W., 1972. Membrane diffusion III: Influence of solvent composition and permeant solubility on membrane transport. J. Pharm. Sci. 61, 61-66.
18. Francoeur, M.L., Golden, G.M., Potts, R.O., 1990. Oleic acid: its effect on stratum corneum in relation to transdermal drug delivery. Pharm. Res. 7, 621.
19. Gabriel, D.L., Simonelli, A.P., 1988. The development and in vitro characterization of gelatin films as a uniphasic transdermal drug delivery system. Pharm. Res. 5, 78.
20. Good, W.R., Powers, M.S., Campbell, P., Schenkel, L., 1985. A new transdermal delivery for estradiol. J. Cont. Rel. 2, 89-97.
21. Guy, R.H., Hadgraft, J., 1987. Transdermal drug delivery: a perspective. J. Cont. Rel. 4, 237-251.
22. Higuchi, W.I., 1962. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51, 802-804.
23. Higuchi, W.I., Yu, C.D., 1987. Prodrugs in transdermal delivery. In: Kydonieus, A.F., Berner, B. (Eds.), Transdermal Delivery of Drugs, vol. 3. CRC Press, Boca Raton, FL, pp. 43-83.
24. Higuchi, W.I., Liu, P., Ghanem, A.H., Song, W., 1987. Mechanism of ethanol effects on the simultaneous transport and metabolism of β-estradiol in hairless mouse skin. In: Proceedings of the International Symposium on Controlled Release and Bioactive Materials, vol. 14. Controlled Release Society, Lincolnshire, IL, pp. 101-102.
25. Hikal, A.H., 1986. Determination of bendroflumethiazide in plasma by high performance liquid chromatography and fluorescence detection. J. Liq. Chromat. 9, 2937-2943.
26. Keith, A.D., 1983. Polymer matrix considerations for transdermal devices. Drug Dev. Ind. Pharm. 9, 604-625.
27. Kim, S.W., Okano, T., Bae, Y.H., Hsu, R., Lee, S.J., 1987. Hydrophilic-hydrophobic balanced polymers controlled delivery of drug. In: Proceedings of the International Symposium on Controlled Release and Bioactive Materials, vol. 14. Controlled Release Society, Lincolnshire, IL, pp. 33-38.
28. Laughlin, T.J., Adair, T.R., Perkins, B.H., Dunn, R.L., 1987. Hydrogel delivery systems based on polymer alloys. In: Proceedings of the International Symposium on Controlled Release and Bioactive Materials, vol. 14. Controlled Release Society, Lincolnshire, IL, pp. 39-40.
29. McDaid, D.M., Deasy, P.B., 1996. Formulation development of a transdermal drug delivery system for amlodipine base. Int. J. Pharm. 133, 71-83.
30. Miller, K.J., Rao, Y.K., Goodwin, S.R., Westermann-Clark, G.B., Shah, D.O., 1993. Solubility and in vitro percutaneous absorption of teracaine from solvents of propylene glycol and saline. Int. J. Pharm. 98, 101.
31. Mills, T., Roberson, J.C. (Eds.), 1987. Instrumental Data for Drug Analysis, vol. 1, 2nd edition. Elsevier, New York, pp. 184-185.
32. Morimoto, Y., Sugibayashi, K., Hosoya, K., Higuchi, W.I., 1986. Penetration enhancing effect of azone on the transport of 5-fluorouracil across hairless mouse skin. Int. J. Pharm. 32, 31-38.
33. Nagai, T., Santoh, Y., Nambu, N., 1983. Percutaneous absorption of propranolol from gel ointment. Acta Pharm. Suec. 20, 47-48.
34. Nagai, T., Santoh, Y., Nambu, N., Machida, Y., 1985. Percutaneous absorption of propranolol from gel ointment in rabbits. J. Cont. Rel. 1, 239-246.
35. Niazy, E.M., 1996. Differences in penetration-enhancing effect of azone through excised rabbit, rat, hairless mouse, guinea pig and human skins. Int. J. Pharm. 130, 225-230.
36. Ogiso, T., Shintani, M., 1990. Mechanism for the enhancement effect of fatty acids on the percutaneous absorption of propranolol. J. Pharm. Sci. 79, 235.
37. Ogiso, T., Iwaki, M., Tanino, T., Yatomi, M., Tsujimoto, C., 1993. Percutaneous absorption of terodiline and the membrane-controlled transdermal therapeutic system. Int. J. Pharm. 98, 113-120.
38. Panchagnula, R., Ritschel, W.A., 1991. Development and evaluation of an intracutaneous depot formulation of corticosteroids using transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies. J. Pharm. Pharmacol. 43, 609-614.
39. Pavliv, L., Freebern, K., Wilke, T., Chiang, C.C., Shetty, B., Tyle, P., 1994. Topical formulation development of a novel thymidylate synthase inhibitor for the treatment of psoriasis. Int. J. Pharm. 105, 227-233.
40. Pywell, E.J., Yalkowsky, S.H., Collett, J.H., 1986. The effect of a rate controlling membrane on release from poly-HEMA hydrogels. Drug Dev. Ind. Pharm. 12, 1767-1775.
41. Reynolds, J.E. (Ed.), 1982. Martindale: The Extra Pharmacopoeia, 28th edition. The Pharmaceutical Press, London, p. 584.
42. Ritschel, W.A., Panchagnula, R., Stemmer, K., Ashraf, M., 1991. Development of intracutaneous depot for drugs. Skin Pharmacol. 4, 235-245.
43. Shah, J.C., 1996. Application of kinetic model to in vitro percutaneous permeation of drugs. Int. J. Pharm. 133, 179-189.
44. Sheth, N.V., Freeman, D.J., Higuchi, W.I., Spruance, S.L., 1986. The influence of azone, propylene glycol and polyethylene glycol on the in vitro skin permeation of trifluorthymidine. Int. J. Pharm. 28, 201-209.
45. Southwell, D., Barry, B.W., 1984. Penetration enhancement in human skin: effect of 2-pyrrolidone, dimethylformamide, and increased hydration on finite dose permeation of aspirin and caffeine. Int. J. Pharm. 22, 291-298.
46. Sprang-Brunner, B.H., Speiser, P.P., 1975. Release of drugs from homogenous ointments containing drug in solution. J. Pharm. Pharmacol. 28, 23-28.
47. Stoughton, R.B., 1982. Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. Arch. Dermatol. 118, 474-477.
48. Stoughton, R.B., McClure, W.O., 1985. Azone: a new non-toxic enhancer of cutaneous penetration. Drug Dev. Ind. Pharm. 37, 578-580.
49. Thacharodi, D., Rao, K.P., 1996. Collagen membrane controlled transdermal delivery of propanolol hydrochloride. Int. J. Pharm. 131, 97-99.
50. Turi, J.S., Danielson, D., Woltersom, J.W., 1979. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate. J. Pharm. Sci. 68, 275.
51. Viegas, T.X., Hikal, A.H., Cleary, R.W., 1988. Formulation of penetration enhancers in polymers. Drug Dev. Ind. Pharm. 14, 855-866.
52. Watkinson, A.C., Madgraft, J., Bye, A., 1991. Aspects of the transdermal delivery of prostaglandins. Int. J. Pharm. 74, 229-236.
53. Wilding, I.R., Davis, S.S., Rimoy, G.H., Rubin, P., Kurihara-Bergstrom, T., Tipnis, V., Berner, B., Nightingale, J., 1996. Pharmacokinetic evaluation of transdermal buprenorphine in man. Int. J. Pharm. 132, 81-87.
54. Wolff, M., Cordes, G., Luckow, V., 1988. In vitro and in vivo release of nitroglycerine from a transdermal therapeutic system. Pharm. Res. 2, 23-29.
55. Wotton, P.K., Mollgaard, B., Hadgraft, J., Hoelgaard, A., 1985. Vehicle effect on topical delivery III. Effect of azone on the percutaneous permeation of metronidazole and propylene glycol. Int. J. Pharm. 24, 19-26.
56. Yum, S.I., Lee, E.S., Taskovich, F., Theeuwes, F., 1987. Mechanism of action of ethanol as flux enhancer for drug permeation through human skin. In: Proceedings of the International Symposium on Controlled Release and Bioactive vol. 14. Controlled Release Society, Lincolnshire, IL, pp. 103-104.